Latest News - Elevance Health
Top Corporates Hub
Elevance Health
U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership
18.08.2026 04:41
In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.
IHF: Healthcare Dashboard For August
16.08.2026 08:06
Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs
14.08.2026 09:48
Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
07.08.2026 15:47
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Elevance Health (ELV) After Its Cancer Care Push, Does The Valuation Still Look Attractive##
01.08.2026 09:12
Elevance Health (ELV) recently highlighted an expanded connected cancer care model that uses predictive analytics and dedicated oncology support to coordinate treatment, reduce avoidable complications, and provide more personalized resources across patients’ entire care journeys. See our latest analysis for Elevance Health. Against this backdrop, Elevance Health’s share price is US$375.84, with a year to date share price return of 6.09%. The 1 month share price return is down 9.70%, although...
Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giant
31.07.2026 07:00
Gail Boudreaux credits collegiate athletics with helping to shape her leadership style.
Investors’ Favour Strengthens Elevance Health’s (ELV) Rebound
30.07.2026 13:31
Investment management company Vulcan Value Partners recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Vulcan Value Partners prioritizes long-term returns and lower risk over short-term performance. In the quarter, the Large Cap Composite (Net) returned 9.5%, the Small Cap Composite (Net) returned 13.3%, the Focus Composite (Net) returned 10.4%, the […]
Centene Q2 Earnings Beat Estimates on Increasing Premiums
28.07.2026 16:04
CNC's Q2 earnings and revenues top estimates as stronger premium and service revenues drive results despite lower membership and higher medical costs.
Elevance Health Pick of the Week at Smart Insider Following CEO, Chairman Share Purchases
28.07.2026 14:14
Elevance Health (ELV) was Smart Insider's stock pick of the week after Chief Executive Gail Boudreau
GreensKeeper Value Fund Q2 2026 Portfolio Update
27.07.2026 08:26
Our top performer in the second quarter was ICON plc, which gained 57%. Our largest detractor during the quarter was Intercontinental Exchange, which declined 21.7%. Read more here.
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
24.07.2026 16:39
HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.
This Medicaid Insurer’s Stock Has Climbed in 2026. Investors Still Have Doubts.
22.07.2026 06:00
Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.
UnitedHealth stock jumps on Q2 earnings, raises full-year outlook
16.07.2026 14:54
Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.
Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive
16.07.2026 14:14
Bernstein SocGen Group lifted its Elevance Health price target to US$482 from US$424, putting fresh attention on how analysts are reassessing the stock. Many research firms are sounding more constructive, pointing to steadier medical cost trends, support from Healthcare Services earnings, and a calmer policy backdrop, while still highlighting Medicaid and specialty drug costs as key risks. Read on to see what is driving this evolving analyst narrative and how you can keep track of the moving...
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
16.07.2026 13:24
UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
16.07.2026 08:17
Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455
16.07.2026 08:02
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $399 to $455.
Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $457
16.07.2026 07:38
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $480 to $457.
Baird Maintains Neutral on Elevance Health, Raises Price Target to $393
16.07.2026 07:15
Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $331 to $393.
Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets
16.07.2026 03:24
Elevance Health (NYSE:ELV) reported second quarter results that exceeded internal expectations. The company raised its full year guidance following the quarterly update. Management outlined plans to exit additional underperforming Medicaid markets. Elevance Health highlighted a focus on expanding Medicare Advantage and Carelon health services. Elevance Health is one of the largest U.S. managed care companies, with a broad footprint across commercial, Medicaid, Medicare Advantage, and health...